30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development.

J Endocrinol · 2017 · PMC5488394 · PMID 28634268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

No significant difference was apparent between potassium oxprenoate and spironolactone in all three studies with respect to the urinary Na + /K + ratio demonstrating that RU 28318 has an antimineralocorticoid effect identical to that produced by the same molar dose of spironolactone.

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.